{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:51:02Z","timestamp":1781700662334,"version":"3.54.5"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:p>A central tension in pediatric research ethics arises from our desire to protect children from harm while also allowing progress toward discoveries that could improve child health. A prime example of this tension is research on a controversial yet increasingly common practice: the use of cannabis by women to treat nausea and vomiting of pregnancy. Studies of cannabis use in pregnancy face a combination of ethical hurdles because of the inclusion of pregnant women and involvement of a schedule I controlled substance. Given the growing need for research on the safety and efficacy of cannabis for nausea and vomiting of pregnancy, we reflect on the multiple historical contexts that have contributed to the challenge of studying cannabis use during pregnancy and make a case for the ethical rationale for such research.<\/jats:p>","DOI":"10.1542\/peds.2020-0818r","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T13:25:13Z","timestamp":1596201913000},"page":"S93-S98","source":"Crossref","is-referenced-by-count":9,"title":["Protection Versus Progress: The Challenge of Research on Cannabis Use During Pregnancy"],"prefix":"10.1542","volume":"146","author":[{"given":"Katherine E.","family":"MacDuffie","sequence":"first","affiliation":[{"name":"Departments of Speech and Hearing Sciences,"},{"name":"Seattle Children\u2019s Hospital, Treuman Katz Center for Pediatric Bioethics, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M.","family":"Kleinhans","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaeley","family":"Stout","sequence":"additional","affiliation":[{"name":"Scripps College, Claremont, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wilfond","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital, Treuman Katz Center for Pediatric Bioethics, Seattle, Washington; and"},{"name":"Pediatrics, School of Medicine, University of Washington, Seattle, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"1","key":"2021121011400779800_B1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2393-9-26","article-title":"Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race\/ethnicity","volume":"9","author":"Lacasse","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"2021121011400779800_B2","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1067\/mob.2002.122594","article-title":"Nausea and vomiting in pregnancy: the problem of perception\u2013is it really a disease?","volume":"186","author":"Miller","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2021121011400779800_B3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12884-018-2093-6","article-title":"Getting through the day: a pilot qualitative study of U.S. women\u2019s experiences making decisions about anti-nausea medication during pregnancy","volume":"18","author":"Figueroa Gray","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"2021121011400779800_B4","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1067\/mob.2002.122605","article-title":"The burden of illness of severe nausea and vomiting of pregnancy in the United States","volume":"186","author":"Attard","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2021121011400779800_B5","first-page":"719","article-title":"Hyperemesis gravidarum: current perspectives","volume":"6","author":"McCarthy","year":"2014","journal-title":"Int J Womens Health"},{"issue":"6","key":"2021121011400779800_B6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajog.2013.11.035","article-title":"Hyperemesis gravidarum and long-term health of the offspring","volume":"210","author":"Ayyavoo","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2021121011400779800_B7","first-page":"CD007575","volume-title":"Cochrane Database Syst Rev","author":"Matthews","year":"2015"},{"issue":"19","key":"2021121011400779800_B8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.2010.1652","article-title":"Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials","volume":"304","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"issue":"16","key":"2021121011400779800_B9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMp1210007","article-title":"Reform, regulation, and pharmaceuticals\u2013the Kefauver-Harris Amendments at 50","volume":"367","author":"Greene","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121011400779800_B10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/tera.1420270216","article-title":"Teratogen update: bendectin","volume":"27","author":"Holmes","year":"1983","journal-title":"Teratology"},{"issue":"12","key":"2021121011400779800_B11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMp1316042","article-title":"FDA approval of doxylamine-pyridoxine therapy for use in pregnancy","volume":"370","author":"Slaughter","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121011400779800_B12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/bdra.10034","article-title":"Bendectin and birth defects. II: x1cological analyses","volume":"67","author":"Kutcher","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"2021121011400779800_B13","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG practice bulletin no. 189: nausea and vomiting of pregnancy","volume":"131","author":"Committee on Practice Bulletins-Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2021121011400779800_B14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jogc.2017.10.024","article-title":"Ondansetron in pregnancy and the risk of congenital malformations: a systematic review","volume":"40","author":"Lavecchia","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"2021121011400779800_B15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2021121011400779800_B16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod Toxicol"},{"issue":"9","key":"2021121011400779800_B17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2021121011400779800_B18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AOG.0000000000001388","article-title":"Ondansetron use in pregnancy and birth defects: a systematic review","volume":"127","author":"Carstairs","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121011400779800_B19","first-page":"180","article-title":"Medicinal cannabis: history, pharmacology, and implications for the acute care setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"P T"},{"issue":"1","key":"2021121011400779800_B20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctcp.2005.09.006","article-title":"Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against \u2018morning sickness\u2019","volume":"12","author":"Westfall","year":"2006","journal-title":"Complement Ther Clin Pract"},{"issue":"10","key":"2021121011400779800_B21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jamainternmed.2018.3581","article-title":"Association of nausea and vomiting in pregnancy with prenatal marijuana use","volume":"178","author":"Young-Wolff","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2021121011400779800_B22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2019.7982","article-title":"Self-reported medical and nonmedical cannabis use among pregnant women in the United States","volume":"322","author":"Volkow","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"2021121011400779800_B23","doi-asserted-by":"crossref","first-page":"e196471","DOI":"10.1001\/jamanetworkopen.2019.6471","article-title":"Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy","volume":"2","author":"Young-Wolff","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2021121011400779800_B24","first-page":"e104","article-title":"A comparison of meconium screening outcomes as an indicator of the impact of state-level relaxation of marijuana policy","volume":"156","author":"Jones","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2021121011400779800_B25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2019.8734","article-title":"Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes","volume":"322","author":"Corsi","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"2021121011400779800_B26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/AOG.0000000000001649","article-title":"Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis","volume":"128","author":"Conner","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021121011400779800_B27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.2019.8860","article-title":"Cannabis use in pregnancy: a tale of 2 concerns","volume":"322","author":"Silverstein","year":"2019","journal-title":"JAMA"},{"key":"2021121011400779800_B28","unstructured":"Centers for Disease Control and Prevention. What you need to know about marijuana use and pregnancy. 2017. Available at: https:\/\/www.cdc.gov\/marijuana\/pdf\/marijuana-pregnancy-508.pdf. Accessed November 4, 2019"},{"issue":"3","key":"2021121011400779800_B29","doi-asserted-by":"crossref","first-page":"e20181889","DOI":"10.1542\/peds.2018-1889","article-title":"Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes","volume":"142","author":"Ryan","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"2021121011400779800_B30","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/AOG.0000000000002354","article-title":"Committee opinion no. 722: marijuana use during pregnancy and lactation","volume":"130","author":"Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2021121011400779800_B31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ypmed.2018.12.002","article-title":"Women\u2019s perspectives about cannabis use during pregnancy and the postpartum period: an integrative review","volume":"119","author":"Bayrampour","year":"2019","journal-title":"Prev Med"},{"key":"2021121011400779800_B32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.11.028","article-title":"Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use","volume":"196","author":"Chang","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2021121011400779800_B33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/AOG.0000000000002619","article-title":"Recommendations from cannabis dispensaries about first-trimester cannabis use","volume":"131","author":"Dickson","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2021121011400779800_B34","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.pec.2016.06.003","article-title":"\u201cAnything above marijuana takes priority\u201d: obstetric providers\u2019 attitudes and counseling strategies regarding perinatal marijuana use","volume":"99","author":"Holland","year":"2016","journal-title":"Patient Educ Couns"},{"issue":"4","key":"2021121011400779800_B35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/AOG.0000000000001343","article-title":"Obstetric health care providers\u2019 counseling responses to pregnant patient disclosures of marijuana use","volume":"127","author":"Holland","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2021121011400779800_B36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrn3530","article-title":"Effects of Schedule I drug laws on neuroscience research and treatment innovation","volume":"14","author":"Nutt","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2021121011400779800_B37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hast.706","article-title":"Research with pregnant women: new insights on legal decision-making","volume":"47","author":"Mastroianni","year":"2017","journal-title":"Hastings Cent Rep"},{"key":"2021121011400779800_B38","article-title":"Bridging the Divide White Paper: Pregnant Women and Substance Use: Overview of Research & Policy in the United States","author":"Bishop","year":"2017"},{"issue":"1","key":"2021121011400779800_B39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4278\/ajhp.141215-QUAL-625","article-title":"Perinatal illicit drug and marijuana use","volume":"31","author":"Chang","year":"2017","journal-title":"Am J Health Promot"},{"issue":"1","key":"2021121011400779800_B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health Justice"},{"key":"2021121011400779800_B41","first-page":"e0215670","volume-title":"PLoS One","author":"Subbaraman","year":"2019"},{"key":"2021121011400779800_B42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2019.02.017","article-title":"Cannabis use during pregnancy: are we at the verge of defining a \u201cfetal cannabis spectrum disorder\u201d?","volume":"124","author":"Schreiber","year":"2019","journal-title":"Med Hypotheses"},{"issue":"1","key":"2021121011400779800_B43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1037\/0003-066X.43.1.49","article-title":"Ethical and professional dimensions of socially sensitive research","volume":"43","author":"Sieber","year":"1988","journal-title":"Am Psychol"},{"issue":"4","key":"2021121011400779800_B44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11017-004-3146-6","article-title":"Parental refusals of medical treatment: the harm principle as threshold for state intervention","volume":"25","author":"Diekema","year":"2004","journal-title":"Theor Med Bioeth"},{"issue":"5","key":"2021121011400779800_B45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.pcl.2012.07.007","article-title":"Ethical issues in neonatal and pediatric clinical trials","volume":"59","author":"Laventhal","year":"2012","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"2021121011400779800_B46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2105\/AJPH.92.7.1073","article-title":"Risk and responsibility: ethics, Grimes v Kennedy Krieger, and public health research involving children","volume":"92","author":"Mastroianni","year":"2002","journal-title":"Am J Public Health"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/146\/Supplement_1\/S93\/914628\/peds_20200818r.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/146\/Supplement_1\/S93\/914628\/peds_20200818r.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:25:17Z","timestamp":1639182317000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/146\/Supplement_1\/S93\/34504\/Protection-Versus-Progress-The-Challenge-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":46,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-0818r","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}